Education
About Us
Working with TipRanks
Follow Us
Sensus Healthcare (SRTS)
NASDAQ:SRTS
SRTS Stock Chart & Stats
$3.22
-$0.31(-4.45%)
At close: 4:00 PM EST
$3.22
-$0.31(-4.45%)
Day’s Range― - ―
52-Week Range$3.03 - $9.33
Previous CloseN/A
Volume208.66K
Average Volume (3M)83.76K
Market Cap
$53.92M
Enterprise Value$55.79M
Total Cash (Recent Filing)$22.16M
Total Debt (Recent Filing)$595.00K
Price to Earnings (P/E)48.7
Beta0.96
Next Earnings
Nov 06, 2025EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding16,440,037
10 Day Avg. Volume91,503
30 Day Avg. Volume83,757
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)2.02
Price to Sales (P/S)2.70
P/FCF Ratio-101.97
Enterprise Value/Market Cap1.03
Enterprise Value/Revenue1.49
Enterprise Value/Gross Profit2.85
Enterprise Value/Ebitda-65.64
Forecast
1Y Price Target
$8.00Price Target Upside148.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
PartnershipsThe company engaged Radiology Oncology Systems as a primary distribution partner to hospital-based radiation oncology departments and freestanding oncology centers nationwide.
Reimbursement OpportunitiesMedicare proposed a physician fee schedule that would significantly increase reimbursement for the delivery of a code of SRT.
Sales GrowthSensus anticipates surpassing 900 capital sales during Q2, with expectations to reach 1,000 in the next 12 months, suggesting strong sales growth.
Bears Say
Regulatory ChallengesA proposed Local Coverage Determination to limit the reimbursement for ultrasound has a negative impact on topline sales since May 2025.
Revenue DeclineTotal revenue was $7.3M, representing 21% YoY decline and missing our projection of $8.3M.
Valuation ConcernsSome investors perceive Sensus and SkinCure as competitors due to similarities in their business models, potentially affecting Sensus' current valuation.
Sensus Healthcare News
SRTS FAQ
What was Sensus Healthcare’s price range in the past 12 months?
Sensus Healthcare lowest stock price was $3.03 and its highest was $9.33 in the past 12 months.
What is Sensus Healthcare’s market cap?
Sensus Healthcare’s market cap is $53.92M.
When is Sensus Healthcare’s upcoming earnings report date?
Sensus Healthcare’s upcoming earnings report date is Nov 06, 2025 which is in 22 days.
How were Sensus Healthcare’s earnings last quarter?
Sensus Healthcare released its earnings results on Aug 07, 2025. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of $0.026 by -$0.086.
Is Sensus Healthcare overvalued?
According to Wall Street analysts Sensus Healthcare’s price is currently Undervalued.
Does Sensus Healthcare pay dividends?
Sensus Healthcare does not currently pay dividends.
What is Sensus Healthcare’s EPS estimate?
Sensus Healthcare’s EPS estimate is -0.1.
How many shares outstanding does Sensus Healthcare have?
Sensus Healthcare has 16,440,037 shares outstanding.
What happened to Sensus Healthcare’s price movement after its last earnings report?
Sensus Healthcare reported an EPS of -$0.06 in its last earnings report, missing expectations of $0.026. Following the earnings report the stock price went down -35.327%.
Which hedge fund is a major shareholder of Sensus Healthcare?
Among the largest hedge funds holding Sensus Healthcare’s share is Sheaff Brock Investment Advisors LLC. It holds Sensus Healthcare’s shares valued at 0.
Sensus Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.00 (148.45% Upside)
$8.00 (148.45% Upside)
Blogger Sentiment
Bullish
SRTS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 40.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $3.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.51%
12-Months-Change
Fundamentals
Return on Equity
-1.62%
Trailing 12-Months
Asset Growth
1.18%
Trailing 12-Months
Company Description
Sensus Healthcare
Sensus Healthcare (SRTS) is a medical technology company that specializes in innovative solutions for the treatment of skin cancer and other dermatological conditions. The company primarily focuses on developing and marketing non-invasive therapies, including its flagship product, the Sensus SRT-100, which utilizes superficial radiation therapy for effective treatment. Sensus Healthcare operates in the healthcare sector, targeting dermatologists, oncologists, and healthcare facilities to enhance patient care and treatment outcomes.
SRTS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. On the positive side, there is significant international expansion and promising changes in the Medicare fee schedule that could boost future demand. However, current financial performance shows declines in revenue, gross margin, and a net loss, compounded by challenges related to a proposed LCD affecting reimbursement. While there are positive strategic initiatives and growth opportunities, the financial downturn and reimbursement uncertainties create a balanced sentiment.View all SRTS earnings summariesSRTS Stock 12 Month Forecast
Average Price Target
$8.00
▲(148.45% Upside)
Technical Analysis
Ownership Overview
1.74% Insiders
9.06% Mutual Funds
15.04% Other Institutional Investors
68.56% Public Companies and
Individual Investors